Cargando…

Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury

Acute ischemic and traumatic injury of the central nervous system (CNS) is known to induce a cascade of inflammatory events that lead to secondary tissue damage. In particular, the sterile inflammatory response in stroke has been intensively investigated in the last decade, and numerous experimental...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thom, Vivien, Arumugam, Thiruma V., Magnus, Tim, Gelderblom, Mathias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534474/ https://www.ncbi.nlm.nih.gov/pubmed/28824617 http://dx.doi.org/10.3389/fimmu.2017.00875

Ejemplares similares

Calorie restriction and stroke
por: Manzanero, Silvia, et al.
Publicado: (2011)

Intravenous immunoglobulin (IVIg) dampens neuronal toll-like receptor-mediated responses in ischemia
por: Lok, Ker Zhing, et al.
Publicado: (2015)

Intravenous immunoglobulin (IVIg) provides protection against endothelial cell dysfunction and death in ischemic stroke
por: Widiapradja, Alexander, et al.
Publicado: (2014)

Disease-modifying effect of intravenous immunoglobulin in an experimental model of epilepsy
por: Chen, Min, et al.
Publicado: (2017)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
por: Hoffmann, Jochen H. O., et al.
Publicado: (2019)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases
por: Lee, Lucia, et al.
Publicado: (2021)

Intravenous Immunoglobulin and Immunomodulation of B-Cell – in vitro and in vivo Effects
por: Mitrevski, Milica, et al.
Publicado: (2015)

Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation
por: Mimura, Yusuke, et al.
Publicado: (2022)

Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin
por: Masso-Silva, Jorge Adrian, et al.
Publicado: (2022)

High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
por: Liu, Xiaosheng, et al.
Publicado: (2020)

Autoimmunity After Ischemic Stroke and Brain Injury
por: Javidi, Ehsan, et al.
Publicado: (2019)

Erratum: Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation
Publicado: (2022)

Potential therapeutic approach of intravenous immunoglobulin against COVID-19
por: Kolahchi, Zahra, et al.
Publicado: (2021)

Endothelial Cell Amplification of Regulatory T Cells Is Differentially Modified by Immunosuppressors and Intravenous Immunoglobulin
por: Lion, Julien, et al.
Publicado: (2017)

A Retrospective Observational Study of Adverse Reactions Associated With Intravenous Immunoglobulin Infusion
por: Kato, Hidefumi, et al.
Publicado: (2021)

Intravenous Immunoglobulin Therapy Restores the Quantity and Phenotype of Circulating Dendritic Cells and CD4(+) T Cells in Children With Acute Kawasaki Disease
por: Wang, Nana, et al.
Publicado: (2022)

Induction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate Immunity
por: Kaufman, Gabriel N., et al.
Publicado: (2015)

The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease
por: Pinto, Amelia K., et al.
Publicado: (2021)

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies
por: Perez, Elena E., et al.
Publicado: (2021)

Case report: Scleromyxedema associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins
por: Wang, Shang-shang, et al.
Publicado: (2023)

Case Report: Rheumatoid meningitis with positive NMDAR antibody: A case treated with intravenous immunoglobulin
por: Zhang, Honglian, et al.
Publicado: (2022)

Effect of intravenous immunoglobulin therapy on the prognosis of patients with severe fever with thrombocytopenia syndrome and neurological complications
por: Liu, Yun, et al.
Publicado: (2023)

β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy
por: Nakagawa, Chad, et al.
Publicado: (2023)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

Differences in Anti-Inflammatory Actions of Intravenous Immunoglobulin between Mice and Men: More than Meets the Eye
por: Tjon, Angela S. W., et al.
Publicado: (2015)

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients
por: Pilon, Caroline, et al.
Publicado: (2020)

High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

Stem Cell-Derived Extracellular Vesicles as Potential Therapeutic Approach for Acute Kidney Injury
por: Quaglia, Marco, et al.
Publicado: (2022)

Treatment of Surgical Brain Injury by Immune Tolerance Induced by Peripheral Intravenous Injection of Biotargeting Nanoparticles Loaded With Brain Antigens
por: Tian, Zhen, et al.
Publicado: (2019)

Case Report: Successful Response to Intravenous Immunoglobulin and Steroid Pulses in a Renal Transplant Recipient With Severe Covid-19 Disease and Associated Acute Allograft Failure
por: Rosa-Guerrero, Pedro, et al.
Publicado: (2021)

Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke
por: Yang-Wei Fann, D, et al.
Publicado: (2013)

Improvement in Primary Autoimmune Myelofibrosis Following a Short Course of Steroids and Intravenous Immunoglobulins
por: Prakash, Swathi, et al.
Publicado: (2022)

Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study
por: Chen, Yan, et al.
Publicado: (2022)

Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis
por: Liu, Xiaosheng, et al.
Publicado: (2023)

Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapeutic Strategy for Acute Kidney Injury
por: Li, Jia-Kun, et al.
Publicado: (2021)

Nanobodies as modulators of inflammation: potential applications for acute brain injury
por: Rissiek, Björn, et al.
Publicado: (2014)

Intravenous Immunoglobulin G Suppresses Heat Shock Protein (HSP)-70 Expression and Enhances the Activity of HSP90 and Proteasome Inhibitors
por: Jones, Richard J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1brar362unq4edire6hlfvbthg